Savara Inc.

US$4.83As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SVRAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (6.06%)
Div yield —
ROE (105.48%)
Biotechnology
Beta (5Y) 0.30
PE TTM —
TSR TTM 16.39%
Mkt cap US$1.227B
ROIC (55.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.70
(2.68%)
(63.15%)
Hold 5|8|3|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.05
2.18%
16.02%
20.83%
26.18%
Revenue$M
113.3
111.8
115.2
116.1
9.58%
5.15%
6.79%
3.38%
Peers (US$1.227B)
Cap (US$)
PE
1.225B
10.77x
1.221B
0.652x
1.214B
—
Capital
TTM
5Y
10Y
Leveragex
0.667
—
—
EBIT/Intx
0.960
0.340
0.302
Own earn%
37.82
38.66
42.49
Sh yield%
46.15
38.42
37.93
Owners
Insiders/Inst%
1.57
55.30
Short interest%
1.37
SBC / revenue%
4.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
16–21
$1 testx
0.0
Incr. ROIC%
12